Lonza Group Ag (OTCMKTS:LZAGY) Sees Large Drop in Short Interest

Lonza Group Ag (OTCMKTS:LZAGY) saw a large drop in short interest during the month of July. As of July 31st, there was short interest totaling 16,610 shares, a drop of 70.7% from the July 15th total of 56,620 shares. Approximately 0.0% of the shares of the company are sold short. Based on an average daily trading volume, of 100,225 shares, the days-to-cover ratio is presently 0.2 days.

Lonza Group Price Performance

LZAGY traded down $1.35 on Friday, reaching $69.06. The company had a trading volume of 19,950 shares, compared to its average volume of 41,112. Lonza Group has a fifty-two week low of $58.53 and a fifty-two week high of $73.85. The company’s fifty day moving average is $67.71 and its 200 day moving average is $65.65. The company has a quick ratio of 1.77, a current ratio of 2.24 and a debt-to-equity ratio of 0.42.

Lonza Group Company Profile

Lonza Group is a Swiss multinational life sciences company that provides products and services to the pharmaceutical, biotech and specialty ingredients markets. Headquartered in Switzerland, the company operates globally with manufacturing and research facilities across Europe, North America and Asia, serving customers involved in drug discovery, development and commercial production. Lonza’s client base ranges from large pharmaceutical firms to emerging biotech companies and manufacturers of consumer health and specialty chemical products.

The company’s core activities center on contract development and manufacturing (CDMO) for small molecules and biologics, including process development, clinical and commercial-scale manufacturing, and fill–finish services.